| Primary |
| Asthma |
28.6% |
| Haemangioma |
28.6% |
| Pancreatitis |
28.6% |
| Paraneoplastic Syndrome |
14.3% |
|
| Medication Error |
40.0% |
| Gastric Cancer |
10.0% |
| Paralysis |
10.0% |
| Phaehyphomycosis |
10.0% |
| Pneumocystis Jiroveci Pneumonia |
10.0% |
| Rectal Cancer |
10.0% |
| Urine Output Decreased |
10.0% |
|
| Secondary |
| Systemic Lupus Erythematosus |
22.2% |
| Dermatomyositis |
10.2% |
| Rheumatoid Arthritis |
7.4% |
| Immunosuppression |
6.5% |
| Asthma |
5.6% |
| Bronchitis |
5.6% |
| Sinusitis |
5.6% |
| Colitis Ulcerative |
4.6% |
| Castleman's Disease |
3.7% |
| Polymyositis |
3.7% |
| Chronic Lymphocytic Leukaemia |
2.8% |
| Haemangioma |
2.8% |
| Liver Transplant |
2.8% |
| Product Used For Unknown Indication |
2.8% |
| Renal Transplant |
2.8% |
| Rhinitis Allergic |
2.8% |
| Wegener's Granulomatosis |
2.8% |
| Acute Lymphocytic Leukaemia |
1.9% |
| Alveolitis Allergic |
1.9% |
| Choroidal Effusion |
1.9% |
|
| Chorioretinopathy |
18.0% |
| Meningitis Cryptococcal |
8.0% |
| Respiratory Failure |
8.0% |
| Systemic Lupus Erythematosus |
8.0% |
| Pneumonia |
6.0% |
| Septic Shock |
6.0% |
| Drug Ineffective |
4.0% |
| No Therapeutic Response |
4.0% |
| Pemphigus |
4.0% |
| Shock |
4.0% |
| Spinal Cord Compression |
4.0% |
| Tuberculous Pleurisy |
4.0% |
| Vasculitis |
4.0% |
| Ventricular Hypertrophy |
4.0% |
| Wegener's Granulomatosis |
4.0% |
| Abdominal Pain Upper |
2.0% |
| Anaphylactic Reaction |
2.0% |
| Bronchitis |
2.0% |
| Candida Pneumonia |
2.0% |
| Cutaneous Leishmaniasis |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.8% |
| Asthma |
18.3% |
| Pain |
13.3% |
| Juvenile Arthritis |
6.7% |
| Imaging Procedure |
3.3% |
| Nuclear Magnetic Resonance Imaging |
3.3% |
| Prophylaxis |
3.3% |
| Renal Failure |
3.3% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Wheezing |
2.8% |
| Arthritis |
2.2% |
| Bronchial Hyperactivity |
2.2% |
| Cough |
2.2% |
| Immunoglobulin Therapy |
2.2% |
| Pain In Extremity |
2.2% |
| Rhinitis Allergic |
2.2% |
| Croup Infectious |
1.7% |
| Dermatitis Atopic |
1.7% |
| Dyspnoea |
1.7% |
| Oesophageal Atresia |
1.7% |
|
| Respiratory Distress |
10.8% |
| Vomiting |
10.8% |
| Wheezing |
10.8% |
| Headache |
8.1% |
| Pharmaceutical Product Complaint |
5.4% |
| Pyrexia |
5.4% |
| Scoliosis |
5.4% |
| Sickle Cell Anaemia With Crisis |
5.4% |
| Therapeutic Agent Toxicity |
5.4% |
| Thrombocytopenia |
5.4% |
| Abdominal Distension |
2.7% |
| Arthralgia |
2.7% |
| Asthma |
2.7% |
| Biopsy Lung |
2.7% |
| Dehydration |
2.7% |
| Dysphagia |
2.7% |
| Ejection Fraction Decreased |
2.7% |
| Erythema Multiforme |
2.7% |
| Haematochezia |
2.7% |
| Haemoglobin Decreased |
2.7% |
|
